In 2025, Acme United Corporation (US: ACU – $43.41) delivered record sales and earnings, achieving the strongest financial performance in its history despite a year marked by volatility and uncertainty. The Company navigated tariff disruptions, shifting customer demand, and global supply chain challenges to produce improved results across most of its key metrics. Several initiatives strengthened the Company’s long-term competitive position in 2025. The first aid division introduced the RFID SmartCompliance ...

Company Overview - Acme United Corporation (ACU) shares increased by 5% to $46 in the last trading session, contrasting with a 1% loss over the previous four weeks, indicating a strong trading volume [1] - The company is showing resilience and operational discipline, effectively managing tariff-related disruptions while achieving steady growth and improved profitability [2] Financial Performance - Acme United is projected to report quarterly earnings of $0.55 per share, reflecting a year-over-year increase of 34.2%, with revenues expected to reach $47.1 million, up 2.5% from the same quarter last year [3] - However, the consensus EPS estimate has been revised down by 1.8% over the last 30 days, which typically does not correlate with price appreciation [4] Market Position - The company is expanding its presence in first aid and medical products, supported by strong international momentum and strategic acquisitions, such as My Medic, which positions it to capture additional market share and diversify its revenue [2] - Acme United holds a Zacks Rank of 3 (Hold), indicating a neutral outlook compared to other stocks in the Consumer Products - Discretionary industry [4]

Financial Performance - In 2025, net sales increased by $2,051,825, or 1%, to $196,541,816 compared to $194,489,991 in 2024[147] - Gross profit was $77,409,848, representing 39.4% of net sales in 2025, compared to $76,350,824, or 39.3% of net sales in 2024[150] - Operating income rose to $14,724,514 in 2025, an increase of $584,572 from $14,139,942 in 2024[152] Expenses and Taxation - Net interest expense decreased by $382,723 to $1,559,920 in 2025 from $1,942,643 in 2024[154] - Income tax expense was $2,933,201 in 2025, with an effective tax rate of 22%, compared to $2,270,058 and 18% in 2024[156] Inventory and Capital Expenditures - Inventory increased by approximately $3.6 million, or 6%, during 2025[158] - Capital expenditures in 2025 were $10,651,913, up from $7,148,648 in 2024, primarily due to the purchase of the new facility[166] Debt and Financial Outlook - As of December 31, 2025, total debt outstanding under the revolving credit facility decreased by approximately $5.8 million compared to the previous year[161] - The Company expects cash on hand and generated from operations, along with available funds under its revolving credit facility, to be sufficient for planned operations for at least the next twelve months[167] Acquisition - The Company acquired a manufacturing and distribution center in Mt. Pleasant, TN for approximately $6.0 million in July 2025[162]

In 2025, Acme United Corporation (US: ACU – $42.50) delivered record sales and earnings, achieving the strongest financial performance in its history despite a year marked by volatility and uncertainty. The Company navigated tariff disruptions, shifting customer demand, and global supply chain challenges to produce improved results across most of its key metrics. For the quarter ended December 31, 2025, net sales rose to $47.5 million, compared to $45.9 million in the fourth quarter of 2024, representing a ...

Financial Data and Key Metrics Changes - Acme United reported record sales and earnings in 2025, with net sales of $196.5 million, net income of $10.2 million, and earnings per share of $2.49, reflecting a 1% increase in sales compared to 2024 [3][10] - The gross margin for the fourth quarter was 38.2%, slightly down from 38.7% in 2024, while the annual gross margin was 39.4%, up from 39.3% in 2024 [11] - Net income for the fourth quarter increased by 10% to $1.9 million, and for the year, it rose by 2% compared to 2024 [13] Business Line Data and Key Metrics Changes - Sales of first aid and medical products were strong, while school and office products saw a decline due to tariff uncertainties [10][11] - The Westcott team expanded market share in cutting tools, particularly in the craft market, and introduced differentiated products using patented non-stick technology [5] - The acquisition of My Medic contributed approximately $19 million in revenues, enhancing the first aid segment [8][22] Market Data and Key Metrics Changes - Net sales in Europe increased by 22% in local currency for the fourth quarter and 4% for the year, driven by the acquisition of cutting and sharpening tools [11] - In Canada, net sales increased by 14% in local currency for the quarter and 16% for the year, with strong performance in first aid products [11] Company Strategy and Development Direction - The company is focusing on expanding its first aid and medical segments, with plans to integrate My Medic into its offerings and explore selective retail partnerships [21][24] - Investments in domestic production and international sourcing are expected to position the company well for growth in 2026 [9] - Future acquisitions may target both first aid and medical segments, as well as suppliers of components for existing products [25] Management's Comments on Operating Environment and Future Outlook - Management acknowledged challenges from high inflation, interest rates, and supply chain disruptions but expressed optimism about the company's positioning and growth potential [2][9] - The company anticipates a return to normal merchandising and promotion in the retail market as it moves into 2026 [9] Other Important Information - Acme United's bank debt decreased from $21.5 million in 2024 to $18.5 million in 2025, reflecting lower debt levels and interest rates [13] - The company generated $13 million in free cash flow before the purchase of a new facility in Tennessee for $6 million [14] Q&A Session Summary Question: Integration of My Medic and its revenue multiple - Management indicated that My Medic will be integrated into the first aid offering, with expected revenues of $19 million and an EBITDA of $1 million to $1.5 million, with a purchase price of $18.6 million including an earn-out and holdback [19][22] Question: Retail distribution for My Medic products - Management stated that the distribution will be selective and may include existing retailers, with plans still being developed [24] Question: Future acquisitions focus - Management noted that future acquisitions could be in first aid, medical, or components suppliers, with a focus on expanding capabilities in pre-hospital emergencies [25]

Financial Data and Key Metrics Changes - Acme United reported record sales and earnings for 2025, with net sales of $196.5 million, net income of $10.2 million, and earnings per share of $2.49, reflecting a 1% increase in sales compared to 2024 [3][10] - The gross margin for the fourth quarter was 38.2%, slightly down from 38.7% in 2024, while the annual gross margin was 39.4%, up from 39.3% in 2024 [11] - SG&A expenses for the fourth quarter were $15.2 million, or 32% of sales, compared to $15.5 million, or 34% of sales in the same period of 2024 [12] - Net income for the fourth quarter was $1.9 million, or $0.46 per diluted share, a 10% increase from $1.7 million, or $0.41 per diluted share in Q4 2024 [13] Business Line Data and Key Metrics Changes - Sales of first aid and medical products were strong, while school and office products saw a decline due to tariff uncertainties [10] - The first aid business in Canada grew significantly, with a 16% increase in sales for the year compared to 2024 [11] - The acquisition of My Medic contributed approximately $19 million in revenues, enhancing the first aid segment [8][22] Market Data and Key Metrics Changes - Net sales in Europe increased by 22% in local currency for the fourth quarter, and 4% for the year, driven by the acquisition of cutting and sharpening tools [11] - Canadian sales increased by 14% in local currency for the fourth quarter and 16% for the year, indicating strong market performance [11] Company Strategy and Development Direction - The company is focusing on expanding its first aid and medical segments, with plans to integrate My Medic into its offerings and enhance direct-to-consumer sales [9][21] - Investments in domestic production and international sourcing are expected to position the company favorably as it enters 2026 [9] - The company is exploring further acquisitions in the first aid and medical sectors, as well as potential vertical acquisitions related to component suppliers [25] Management's Comments on Operating Environment and Future Outlook - Management acknowledged challenges from high inflation, interest rates, and supply chain disruptions but expressed optimism about the company's positioning for growth in 2026 [2][9] - The company anticipates a return to normal merchandising and promotion in the retail market, which is expected to benefit sales [9] Other Important Information - Acme United purchased a new facility in Tennessee for approximately $6 million to expand production capabilities [7] - The company generated $13 million in free cash flow before the purchase of the new facility [14] Q&A Session Summary Question: Integration of My Medic and revenue details - Management indicated that My Medic will be integrated into the first aid offerings and aims to expand its direct-to-consumer business, with revenues of approximately $19 million and an EBITDA of $1 million to $1.5 million [19][22] Question: Future acquisitions - Management stated that future acquisitions could be in the first aid and medical sectors or in cutting tools, focusing on expanding horizontal distribution and addressing pre-hospital emergencies [25]

Financial Data and Key Metrics Changes - Acme United reported record sales and earnings in 2025, with net sales of $196.5 million, net income of $10.2 million, and earnings per share of $2.49, reflecting a 2% increase in net income and diluted earnings per share compared to 2024 [3][12] - The gross margin for the fourth quarter was 38.2%, slightly down from 38.7% in 2024, while the annual gross margin was 39.4%, up from 39.3% in 2024 [10] - SG&A expenses for the fourth quarter were $15.2 million, or 32% of sales, compared to $15.5 million, or 34% of sales in the same period of 2024 [11] Business Line Data and Key Metrics Changes - Sales of first aid and medical products were strong, while sales of school and office products declined due to tariff uncertainties [9] - The Westcott team expanded market share in cutting tools, particularly in the craft market, and introduced differentiated products using patented non-stick technology [5] - The acquisition of My Medic, a direct-to-consumer supplier of advanced first aid products, generated revenues of approximately $19 million in 2025 [7][22] Market Data and Key Metrics Changes - Net sales in Europe increased by 22% in local currency for the fourth quarter, and annual sales increased by 4% compared to 2024 [10] - In Canada, net sales increased by 14% in local currency for the quarter and 16% for the year, driven by strong sales of first aid products [10] Company Strategy and Development Direction - The company is focused on expanding its first aid and medical segments, with plans to integrate My Medic into its offerings and enhance direct-to-consumer sales [8][21] - Investments in domestic production and international sourcing are expected to position the company well for growth in 2026 [8] - Future acquisitions may target both first aid and medical segments, as well as suppliers of components for existing products [26] Management's Comments on Operating Environment and Future Outlook - Management acknowledged challenges from a high inflation environment, supply chain disruptions, and tariff changes but expressed optimism about the company's positioning for growth [2][8] - The company anticipates a return to more normal merchandising and promotion in the retail market as it moves into 2026 [8] Other Important Information - Acme United purchased a 78,000 sq ft plant in Tennessee for approximately $6 million to expand production of various first aid products [6] - The company generated $13 million in free cash flow before the purchase of the new facility [13] Q&A Session Summary Question: Integration of My Medic and revenue multiple - Management indicated that My Medic will be integrated into the first aid offering and aims to expand its direct-to-consumer business, with an EBITDA of approximately $1 million to $1.5 million [19][22] Question: Retail distribution for My Medic products - Management stated that the distribution will be selective and is still being developed, with potential overlap with existing retailers [25] Question: Future acquisitions focus - Management noted that future acquisitions could be opportunistic, focusing on expanding both first aid and medical segments or acquiring suppliers of components [26]

Acme United Corporation. (ACU) came out with quarterly earnings of $0.46 per share, in line with the Zacks Consensus Estimate . This compares to earnings of $0.41 per share a year ago. These figures are adjusted for non-recurring items. A quarter ago, it was expected that this company would post earnings of $0.63 per share when it actually produced earnings of $0.46, delivering a surprise of -26.98%.Over the last four quarters, the company has not been able to surpass consensus EPS estimates.Acme United, wh ...

Financial Performance - Net sales for Q4 2025 were $47.5 million, a 3% increase from $45.9 million in Q4 2024[1] - Net income for Q4 2025 was $1.9 million, or $0.46 per diluted share, representing a 10% increase in net income and a 12% increase in diluted earnings per share compared to Q4 2024[2] - U.S. segment net sales were constant in Q4 2025 compared to Q4 2024, but declined 1% for the full year[4] - European net sales increased 31% in U.S. dollars and 22% in local currency for Q4 2025, with an 8% increase in net sales for the full year[5] - Canadian net sales increased 14% in both U.S. dollars and local currency for Q4 2025, with the same percentage increase for the full year[6] - Gross margin for Q4 2025 was 38.2%, down from 38.7% in Q4 2024, while the full year gross margin was 39.4%, slightly up from 39.3%[7] Acquisition and Expansion - The company acquired My Medic in January 2026 for $18.7 million, with 2025 revenues of approximately $19 million, aiming to expand its product offerings and distribution[3] Debt and Cash Flow - The company's bank debt less cash decreased to $18.1 million as of December 31, 2025, from $21.5 million a year earlier[8] - The company generated approximately $13.6 million in free cash flow before the purchase of a new $6 million manufacturing facility in Tennessee[9] Assets - Total assets increased to $170.998 million as of December 31, 2025, compared to $162.170 million a year earlier[21]

Core Insights - Acme United Corporation reported a 3% increase in net sales for Q4 2025, reaching $47.5 million compared to $45.9 million in Q4 2024, and a 1% increase for the full year, totaling $196.5 million compared to $194.5 million in 2024 [1] Financial Performance - Net income for Q4 2025 was $1.9 million, or $0.46 per diluted share, reflecting a 10% increase in net income and a 12% increase in diluted earnings per share compared to Q4 2024 [2] - For the full year 2025, net income was $10.2 million, or $2.49 per diluted share, which is a 2% increase in both net income and diluted earnings per share compared to 2024 [2] Business Operations - The company faced challenges in 2025 due to customer uncertainty and increased costs from tariffs, which were imposed in April and fluctuated throughout the year. Retail sales were particularly affected as customers postponed and canceled promotions [3] - In January 2026, Acme United acquired My Medic for $18.7 million, which generated approximately $19 million in revenue in 2025. The integration of My Medic is expected to enhance revenue through expanded product offerings and distribution [3] Segment Performance - U.S. segment net sales remained constant in Q4 2025 compared to Q4 2024, but declined by 1% for the full year due to lower sales of school and office products, despite strong sales in first aid and medical products [4] - European net sales increased by 31% in U.S. dollars and 22% in local currency for Q4 2025, with a full-year increase of 8% in U.S. dollars and 4% in local currency compared to 2024 [5] - Canadian net sales rose by 14% in both U.S. dollars and local currency for Q4 2025, with the same percentage increase for the full year, driven by strong sales of first-aid products [6] Profitability Metrics - Gross margin for Q4 2025 was 38.2%, slightly down from 38.7% in Q4 2024, while the full-year gross margin was 39.4%, up from 39.3% in 2024 [7] Financial Position - As of December 31, 2025, the company's bank debt less cash was $18.1 million, down from $21.5 million in 2024. The company generated approximately $13.6 million in free cash flow and distributed about $2.3 million in dividends during the year [8]